lifescience

Portland-based Bright.md announced this morning that it has raised $3.5M in a funding round, to go towards its healthcare software-as-a-service. Bright.md said the Series A funding came from the Oregon Angel Fund, and also included Seven Pe...

Seattle-based Carena, a startup that provides telemedicine services to hospital systems, said this morning that it has raised $13.3M in a funding round. The funding came from Cambia Health Solutions, McKesson Ventures, Catholic Health Initi...

Seattle-based Juno Therapeutics has settled patent litigation between the company and Novartis, the two said Monday morning. According to the two, Novartis agreed to pay $12.25M plus future milestone and "mid-single digit" royalties to Juno...

Bellevue-based health software developer HealthUnity has been acquired by Texas-based population health software company ZeOmega, the two announced this morning. Financial details of the acquisition were not announced. HealthUnity was ventu...

Kirkland-based Cardiac Dimensions, which is developing a mitral repair device used for treating heart failure, said this morning that it has now raised $43M in its latest funding round. The total comes thanks to a $15.2M tranche of funding....

Seattle-based Adaptive Biotechnologies said Wednesday that it has acquired Sequenta, a developer of immunosequencing products aimed at helping to diagnose and treat cancer, autoimmune disorders, and infection diseases. Financial details of ...

Bothell-based Alder Biopharmaceuticals said in a filing Monday that it is looking to raise another $115M on the markets, via a secondary stock offering. Alder went public on the NASDAQ as ALDR in May. The new stock offering is being underwr...

Seattle-based Juno Therapeutics filed for an IPO this morning, saying that it is looking to raise up to $150M on the NASDAQ Global Market as JUNO. Juno's IPO is being underwritten by Morgan Stanley, J.P. Morgan, Goldman, Sachs & Co., and Le...

Portland-based Bright.md, led by Ray Costantini and Mark Swinth, said this morning that it has raised a $1M, seed funding round for its health software. The funding came from Seven Peaks Ventures, along with the Portland Seed Fund and Orego...

Seattle-based Limeade, a developer of software which helps employers improve the health of their employees, has raised $25M in a fudning round. The funding was led by Oak HC/FT Partners. TVC Capital also participated in the funding. Limeade...

Kirkland-based medical device developer Cardiac Dimensions said this morning that it has raised $8.5M in a financing round. The funding came from Arboretum Ventures, along with M.H. Carnegie & Co. and Lumira Capital. The funding is part of ...

Seattle-based biopharamceuticals developer Juno Therapeutics said this morning that it has raised $134M in a Series B funding. The funding came from ten public mutual funds and other healthcare-focused funds. Names of those exact investors ...

Seattle-based biotechnology company Immune Design is trading flat on the second day after its IPO, after debuting at $12.00 per share. The company priced at the low end of its earlier, estimated IPO range of $12.00 to $14.00 per share. Immu...

Portland-based Galena Biopharma reported yesterday that the biopharmaceuticals firm is in a deal to license the rights for an oral soluble film from Monosol Rx. Galena is using MonoSol's PharmFilm oral soluble film technology for deliverin...

Seattle-based X2 Biosystems, which develops technology, software, and sensors around reducing the issues of sports related concussions, said today that it has partnered with a soccer league to test out its products with female youth soccer ...

Seattle-based Cardiac Insight, the University of Washington spinoff which is developing wearable sensors in the cardiology area, has raised $7M in a Series B funding. The funding came from Welch Allyn, WRF Capital, and other investors. Welc...

Portland-based DesignMedix, a developer of dual-action drugs which help combat drug resistance, has raised $1.5M in a funding round, according to the company. The funding came from the Portland Seed Fund, Bellingham Angels, Oregon Angel Fun...

Seattle-based Adaptive Biotechnologies, which is using gene sequencing technology for clinical diagnostics, said today that it has named Sean Nolan as the company's Chief Technology OFficer. Nolan is a veteran of Microsoft, where he spent t...

Seattle-based Stratos Genomics has received a strategic investment from Roche, the two announced today, to support the development of Stratos' DNA sequencing technology. Size of the investment was not announced. Stratos is led by Allan Step...

Seattle-based Indi, a developer of molecular diagnostics technology, said today that it has raised a total of $47.25M in a combination of equity and debt. The funding included $30.25M in a Series B equity fnding, and $17M in debt financing....

Seattle-based Juno Therapeutics announced this morning that it has raised $176M in a series A funding round, for its cancer immunotherapy efforts. According to the company, the funding came primarily from ARCH Venture Partners and the Alask...

Kirkland-based Cardiac Dimensions, which develops minimally invasive devices for treating heart failure, said today that it has raised $20M in a funding round. The funding was led by M. H. Carnegie & Co. and Lumira Capital, along with other...

Seattle-based Adaptive Biotechnologies has raised $105M in a Series D financing round, which all came from Viking Global Investors. The biotechnology company is working on sequencing technology being targeted at cancer immunotherapy. The co...

Seattle-based biotechnology developer Juno Therapeutics has turned to an investment banker from Morgan Stanley, to serve as Chief Financial Officer for the company. According to Juno Therapeutics, it has named Steve Harr, M.D., as Chief Fin...

Seattle-based biopharmaceuticals developer KinDex Pharmaceuticals has raised $5M in a Series A funding. The funding was led by Polaris Partners. KinDex is specifically targeting Type 2 diabetes, using molecules which modulate regulatory net...

Portland-based medical device developer Semler Scientific, which develops noninvasive devices used to measure arterial blood flow, has dropped its IPO range, saying in a filing last week that it now expects its IPO to be between $7.50 and $...

Everett, Washington-based Fluke Biomedical, which manufactures biomedical test equipment and other scientific instrumentation, said today that it has acquired Unfors RaySafe. Unsors RaysSafe is a developer of diagnostic x-ray and dosage mon...

An Oregon startup--RevMedX--has developed technology that might just help the military--and others--reduce deaths from gunshot wounds, by directly injects special clotting sponges into wounds on the battlefield. In an in-depth profile, Popu...

Seattle-based life sciences product developer NanoString Technologies said in a filing today that it plans to offer up $55M more in a secondary, public stock offering. The company said the new funds will go towards further commercialization...

Seattle-based Clarity Health Services, which provides healthcare care coordination services and technology, said Monday that it has raised $6.6M in a funding round. The round was led by Columbia Pacific Advisors' Opportunity Fund. The compa...

Seattle-based Juno Therapeutics has raised an astounding, $120M in a Series A funding round today, to go towards the launch of a new company to develop immunotherapies for cancer. The startup--spun out of the Fred Hutchinson Cancer Research...

Seattle-based Cell Therapeutics said this morning that it has received $5M, via a milestone payment from Teva Pharmaceutical Industrires. Cell Therapeutics said the pament was related to the achievement of a sales milestone for TRISENOX, wh...

Seattle-based NanoString Technologies has named a new head of its business development efforts, the company announced Wednesday. The life sciences tool developer said it has named David W. Ghesquiere as Senior Vice President, Corporate & Bu...

Seattle-based biopharmaceuticals developer Dendreon announced this morning that it has cut 150 jobs, or about 15 percent of its employees, as it looks to cut cash operating expenses at the company. The company--which has seen slipping sales...

Seattle-based Immune Design announced this morning that it is raising up to $49M in a Series C funding round, split between an immediate investment of $32.5M upfront and an additional $16.5M in the near future, depending on program progress...

Bellevue-based Kona Medical, the developer of ultrasound devices for treating kidney issues, said today that it has raised $10M in a Series D investment. The funding was led by Morningside Group, an investor focused on China, which is the r...

Seattle-based biopharmaceuticals firm Omeros announced this morning that it has appointed Michael K. Inouye as its new Vice President, Commercial Operations. Inouye was previously an executive at Pharmacyclics, and also has served at Telik,...

Seattle-based Immune Design said Thursday that it has named Stephen R. Brady as its Chief Business Officer. Brady was most recently CFO at 3-V Biosciences, and also has served at Proteolix, Lexicon Pharmaceuticals, Lazard Venture Advisors, ...

Seattle-based Indi Molecular, a developer of synthetic replacements for antibodies, has raised $1.5M in a seed funding round. The round was led by Interwest Partners, along with angels. The company--which has licensed technology from the Sc...

Fate Therapeutics, the developer of stem cell technology which started in Seattle, is getting set for its IPO, saying in a regulatory filing this morning that it hopes to sell 4,000,000 shares of its common stock at between $14.00 and $16.0...

Kirkland-based medical device firm Tissue Regeneration Systems has raised $4.6M in a funding round, the firm disclosed this week. The company said the funding came from Venture Investors. The company makes skeleton reconstruction implants u...

Scientists at the University of Washington have teamed up with GE Global Research to work on developing paper-based, disposable devices for detecting infection and disease, the two announced Thursday. According to the two, they've developed...

A new, medical device incubator, Mercury Medical Technologies, has launched today in Bothell, according to the Bothell Biomedical Manufacturing Innovation Zone. According to the group, the new medical device incubator is housed at the Lake ...

Seattle-based NanoString Technologies, the provider of molecular diagnostics and other life sciences tools, was walloped in its IPO on Wednesday, closing down nearly 20 percent below its already low IPO price. The firm closed at $8.06 per s...

Bellevue-based venture investor Ignition Partners has put more money behind a provider of a cloud-based, gamified, corporate wellness service this morning. Keas, which is based in San Francisco, said it has raised $8M in a new funding from ...

Bothell-based Mirabilis Medica, a developer of ultrasound technology aimed at treating uterine fibroids, said Monday that i thas raised $7M in a Series A-1 funding, part of an ongoing $13M funding round. The funding was led by GSR Ventures,...

Seattle-based NanoString Technologies looks like it's going to fast-track its path to an IPO, and has estimated its IPO trading range at between $13.00 and $15.00 per share. The company set its IPO range Thursday in a filing, also saying th...

Redmond-based Mobisante, the developer of tablet-based, ultrasound technology, has raised $4.2M in an ongoing funding round. The firm disclosed the funding via a regulatory filing yestrday. The round is targeted at $5.3M. Details on the fun...

Seattle-based biotechnology developer Oncothyreon disclosed this morning that it has raised $10M in a registered direct offering. The publicly held firm said it has agreed to sell 5,000,000 shares of its common stock and warrants to purchas...

Seattle-based EKOS, the developer of ultrasound tools for treating vascular thrombosis, has been acquired by British biotech company BTG. BTG said it will pay $180M, plus up to $40M in earn out, for EKOS, whose products are used to treat se...

Seattle-based Remote Medical International, a provider of international medical services, said Thursday that it has raised $8M in a funding round. The funding came from Columbia Pacific Management, a Seattle investor which already owns 23 h...

Seattle-bsaed life sciences and molecular analysis systems developer NanoString Technologies has filed for an IPO, saying this morning in a filing that it hopes to raise $86.25M in the offering. The firm has applied to list as NSTG on the N...

Square 1 Bank, a specialized technology banks, said Wednesday that it has bolstered its Seattle presence, to help grow the company's business in the Pacific Northwest. According to Square 1 Bank, Rilus Graham has relocated to Seattle to gro...

Seattle-based BEATbio, a biotechnology firm which says it is looking to develop a novel gene therapy to improve cardiac performance during heart failure, has raised $2.5M in a seed funding round. The firm said the funding came from CET Capi...

What do you get when you cross a tablet PC with an ultrasound system? Redmond-based medical imaging systems developer Mobisante has rolled out a tablet-based, ultrasound imaging system, which it says lets healthcare providers conduct ultras...

Seattle-based Atossa Genetics said Thursday that it has raised $30M more, in a stock purchase agreement with Aspire Capital. The publicly held firm, which is developing diagnostics for breast cancer, said Aspire paid $12.00 per share for $1...

Seattle-based therapeutic antibody developer Theraclone Sciences said this morning that it has raised $14M, in a combination of equity and debt funding. The firm said that $8M of the funding was equity, which came from its existing investor...

Auburn, Washington-based Syntrix Biosystems has scored a big jury award as part of a patent infringement lawsuit, according to life sciences equipment maker Illumina. Illumina said it was ordered to pay the damages to Syntrix, based on a ro...

Seattle-based Blaze Bioscience announced this morning that it has raised $8.5M in a Series A funding round. The firm said the funding came from individual investors, including physicians and biotech executives. The firm said it has now rais...

Redmond-based EndoGastric Solutions, a developer of medical devices used for treating gastrointestinal diseases, has raised $10.0M more in funding, according to a regulatory filing. Details on the funding have yet to be announced. EndoGastr...

Bellevue-based Innovative Pulmonary Solutions said today that it has raised $10M in a Series C funding round--but has moved its headquarters to Minneapolis, Minnesota from Bellevue, and renamed itself to Holaira. The medical device company,...

Seattle-based Kineta, the biopharmaceuticals firm developing treatments for infection and autoimmune diseases, said yesterday that it has scored a new investment from RLB Holdings, the investment group which also owns the New York Yankees. ...

How do you more easily connect with a doctor or nurse about your health? A new service, CareSimple from Seattle-based Carena, is looking to make talking to a doctor or nurse as easily as calling them up on Skype. Accordin to Carena, its new...

Seattle-based Flexminder, a provider of services to help third party health administrators automate flexible spending account claim submissions, has raised $1.4M in a funding round. The round came from Founder's Co-Op, WRF Capital, and othe...

Seattle-based Qliance, the venture-backed operator of primary care clinics for preventative care, minor treatments, and treating chronic health conditions, has raised $8.65M in a new investment, according to a regulatory filing from the com...

Can a high tech device help you avoid back pain? That's the idea behind Seattle-based Madrona Venture Group's latest investment, LUMO BodyTech. LUMO said Wednesday that Madrona led its $5M Series A funding round, which also included Innovat...

Bellevue-based medical devices developer Kona Medical said yesterday that it has added $10M in equity and debt as part of its Series C financing round, bring its total raised in the round to $40M. The firm said it added two, un-named large-...

Seattle-based NanoString Technologies, which develops life science tools for the molecular diagnostics area, said this morning that it has raised $15.3M in a Series E funding round. The round came from Morgan Stanley Expansion Capital and A...

Visterra, a biopharmaceuticals developer focusing on novel medicines to prevent and treat infections, said last week that it has raised $26M in a Series A round, led by the Bill and Melinda Gates Foundation. The funding also include Omega F...

Bothell-based Advanced Microscopy Group, which develops imaging systems for research microscopy, has been acquired by life sciences equipment company Life Technologies. Financial terms of the acquisition were not announced. Life Technologie...

Seattle-based Resolve Bio has raised $5.8M more for its efforts to develop treatments for lupus, according to a report today. The funding came from WRF Capital, New Science Ventures, and Easton Capital. New of the funding first came from Xc...

Seattle-based lifesciences tool developer NanoString Technologies said this morning that it has named James A. Johnson as its new Chief Financial Officer. Johnson joins the firm from Relypsa, where he also served as CFO' he also has been at...

Bellevue-based medical device developer Innovative Pulmonary Solutions has raised $10.6M in a Series B funding round, the firm announced Thursday. The funding came in March of 2012, and was led by Advanced Technology Ventures. Other investo...

ZocDoc, which operates a service which helps users to book doctor's appointments over the Internet, said today that it has arrived in Portland. The startup--which is venture backed by Jeff Bezos and his firm, Bezos Expeditions--has been ava...

Seattle-based Matrix Genetics, a biotechnology firm aimed at producing both renewable fuels and specialty chemicals from algae, said today that it has scored a funding round. The round came from Avista Development, the Spokane-based venture...

Seattle-based NanoString Technologies, the developer of molecular diagnostic tools, said this morning that it has named a new member to its board. The company said it has named Greg Norden, the former Chief Financial Officer of Wyeth, to th...

Seattle-based Carena, a provider of virtual medicine services which provides patients with around-the-click access to registered nurse practitioners via telephone, webcam, and in-person house calls, has raised $14M in a funding round. The f...

Seattle-based Blaze Bioscience, a developer of technology it calls "tumor paint" to help physicians visualize solid, cancer tumors, has raised $5.0M in a Series A financing round, the firm said today. Source of the funding was not announced...

Bellevue-based Kona Medical, a developer of ultrasound-based treatments for high blood pressure, said Wednesday that it has raised $30M in a Series C funding round. The round came from existing Essex Woodlands, Domain Associates, Morgentha...

Seattle-based NanoString Technologies, the developer of life sciences tools used for molecular diagnostics, said today that it has named Bruce J. Seeley as its Senior Vice President and General Manager, Diagnostics. Seeley joins the firm fr...

Seattle-based Medify, which operates an online site which allows users to learn more about health conditions via the experiences of other patients, has been acquired by healthcare social networking provider Alliance Health Networks. Financi...

Seattle-based Cadence Biomedical, a developer of medical devices to help people with severe disabilities to walk, said this morning that it has raised $1.1M in a Series A2 funding round. The funding came from the Sand Hill Angels, Tech Coas...

Bothell-based Alder BioPharmaceuticals, a developer of technology for developing antibodies used in treating cancer, autoimmune diseases, and other diseases, has raised $38M in a Series D funding round, the company said this morning. The fu...

Bellevue-based Talyst, the developer of pharmacy automation tools, reported Thursday that it has partnered with healthcare software firm Medacist Solutions Group. According to the two, Medacist Solutions Group will offer its software to sup...

The acquisition of Bothell-based SonoSite, the provider of ultrasound technology, has completed, FujiFilm said this morning. FujiFilm had said it would pay $995M for SonoSite in December, paying $54.00 per share in cash for the maker of ult...

Seattle-based Amazon Web Services, the web services arm of Amazon.com, said today with the United Stations National Institutes of Health (NIH), that the two have collaborated on publishing a major human genetics database on the web. The ser...

Microsoft billionaire Paul G. Allen is investing an additional, $300M in funding towards the Allen Institute for Brain Science, the institute said Wednesday, putting the total invested in the brain research outfit at $500M. According to the...

HemaQuest Pharmaceuticals, which is developing small molecule therapeutics for treating hemoglobain disorders such as sickle cell disease, said today that it has raised $13M in a Series B extension financing. The firm, which has its researc...

Seattle-based Integrated Diagnostics, the developer of molecular diagnostic products, said this morning that it has closed on $10M in a third tranche of its Series A financing. The funding was led by Interwest Partners, and also included Th...

Bend, Oregon-based Bend Research, a provider of drug-formulation development and manufacturing services, said today that it has inked a deal with Eli Lilly and Company. According to Bend Research, it is making its proprietary spray-dried di...

Seattle-based Vulcan Capital is one of the investors in a developer of personalized medicine products. According to Applied Proteomics, which is based in San Diego, California, Vulcan joined Domain Associates and un-named angels in investin...

Portland-based Cambia Health Solutions, which operates a portfolio of health care information, software, insurance, and other health related companies, said today that it has launched Hubbub Health, a new online service to spur people to li...

The acquisition of Redmond-based Physio-Control, the maker of automatic external defibrillators (AEDs), by private equity firm Bain Capital has completed, Physio-Control said today. The deal had been announced in November. The deal was wort...

Uptake Medical, the developer of treatment for emphysema, has raised a Series C round of funding, the firm said this morning. The company--which has offices in Seattle, but which recently moved its headquarters to Southern California--did n...

Seattle-based Oncothyreon, which is developing treatments for cancer, said yesterday that it has promoted Diana Hausman, M.D., to the position of Chief Medical Officer. Hausman has been Vice President, Clinical Development at the firm since...

Bothell-based ultrasound maker SonoSite is being acquired by Fujifilm Holdings in a deal worth $995M, according to the companies this morning. Fujifilm and Sonosite said that Fufijilm will acquire SonoSite for $54 per share in cash, or appr...

Bothell-based AVI Biopharma, which develops RNA-based therapeutics for rare and infectious diseases, said late Friday that it has chopped its workforce by approximately 28 percent, as part of an effort to "streamline" the firm's infrastruct...

Seattle-based Groove Biopharma, a biopharmaceuticals startup focused on microRNA, said Monday that it has raised $6M in a Series B funding. The firm--formerly known as Mirina--said the funding came from Alexandria Venture Investments, ARCH ...

Issaquah, Washington-based Applied Precision, which develops microscopic imaging products, reported this morning that it has licensed a new set of patents from Yale University. The company did not discuss terms of the license, but said the ...

Bellevue-based Talyst, the developer of pharmacy automation tools, said today that it has launched a mobile app for iOS, which connects to the firm's pharmacy management systems. The firm said the new app, AutoPharm Mobile, provides real ti...

Bellevue-based Talyst, the developer of pharmacy automation products headed by Carla Corkern, said today that it has launched a new, automated storage and pharmacy-grade refrigeration system. The firm said its new AutoCarousel HD software h...

Redmond-based Physio-Control, the provider of defibrillators and other emergency medical equipment, which is a unit of Medtronic, is being sold to private equity firm Bain Capital. Medtronic, which is based in Minneapolis, said it would sel...

Redmond-based Pacific Bioscience Laboratories, the developer of the Clarisonic skin care devices, has been acquired by L'Oreal USA, the firms said Thursday afternoon. Financial terms of the buy were not disclosed. Pacific Bioscience Laborat...

Seattle-based Impel Neuropharma, a developer of biomedical devices, has raised $500,000 in a Series B, angel funding round, the firm said Thursday. Names of those angel investors were not detailed. Impel Neuropharma is developing a medical ...

VisionGate, a developer of non-invasive tests for lung cancer, said today that it has raised $2M out of a $3M funding round. The firm, which has research and development offices in Seattle near the University of Washington, did not disclose...

Seattle-based Immune Design Corp., a biotechnology firm focused on molecular immunology, said today that it has named Guy F. Cipriani as its Chief Business officer. Cipriani was most recently at Cardiome Pharma Corp., and also has served at...

Seattle-based Calypso Medical Technologies, the developer of real-time tumor tracking systems for the radiosurgery and radiotherapy market, has been acquired by Varian Medical Systems, the two firms said Tuesday. Varian will pay approximate...

Bellevue-based RF Surgical Systems, a developer of systems used to keep track of surgical sponges within patients, said Tuesday that it has raised $12M in a new fundraising round. The round was led by Split Rock Partners, and also included ...

Seattle-based Theraclone Sciences, a biotechnology firm focused on developing therapeutic antibodies for treating infectious disease and cancer, said Thursday that it has raised $10.6M in a Series B funding round. The round came from prior ...

Seattle-based Dendreon, the developer of a drugs used to boost the immune systems of prostate cancer patients, said Thursday afternoon that it is laying off 500 of its employees, in the face of sales issues for its drug. The firm said that ...

Kirkland, Washington-based Pathway Medical Technologies, a developer of products for treating Peripheral Arterial Disease (PAD), has been acquired by Bayer Healthcare. Financial terms of the buy were not disclosed. Bayer said the acuqisitoi...

Seattle-based Amnis Corporation, which manufacturer advanced cell imaging systems for the life sciences market, has been acquired by German firm EMD Millipore, the Life Science division of Merck KGaA. Financial terms of the acquisition were...

Redmond-based Microsoft Corp. is looking to siphon off users of Google Health, saying today that it will make it easy for users to migrate their health data from Google Health to Microsoft's own HealthVault service. Google said in June that...

Issaquah-based Spacelabs Healthcare said today that it has launched a new product. The firm said it has launched the Sonicaid Encore, a high performance fetal and maternal monitor, which uses ultrasound to locate and track fetal heartbeat a...

Seattle-based Atossa Genetics, a developer of molecular diagnostics for breast cancer, said this morning that it has raised $6.6M in a new funding round. Source of the new funding was not announced. The firm said the round was oversubscribe...

Seattle-based Stratos Genomics said Wednesday that it has raised $2.1M in a new round of funding. The firm said the funding came from existing investors. The funding will go to continue development of the firm's DNA sequencing method, aimed...

Seattle-based Resolve Therapeutics, a new startup developing treatments for lupus, said today that it has raised $2M in a initial close of a Series A funding round. The round came from New Science Ventures and Easton Capital. Resolve Therap...

Bellevue-based Talyst, a developer of pharmacy automation products, has signed on a hospital in New Jersey. The Hackensack University Medical Center (HUMC) said today that it has implemented the AutoCarousel HD by Talyst, a secure automated...

Redmond-based VacuPractor, a developer of a device for lower back pain treatment, has scored $25,000 from the ZINO Life Fund, the ZINO Society said Monday evening. The ZINO Society said the funding came out of a presentation at the March li...

Seattle-based Avvo, the online directory of doctors and lawyers, is looking to spur more reviews of doctors on the site with a link to a charity. According to Avvo, it will donate $5 to the Melanoma Research Foundation for every doctor revi...

Issaquah, Washington-based Applied Precision, a developer of cellular imaging products for the cell biology and biomedical research market, has been acquired by GE Healthcare, a unit of GE. Financial details of the deal were not disclosed. ...

Bellevue-based Talyst, a developer of pharmacy automation products, said earlier this week that it has signed pharmaceutical wholesaler H.D. Smith as a customer. Talyst said that H.D. Smith is the fourth largest pharmaceuticals wholesaler i...

Seattle-based venture capital firm Frazier Healthcare has completed its acquisition of the Onsite Services unit of CareFusion, the firms said Tuesday. The deal had been announced on January 11th. CareFusion's OnSite SErvices arm provides me...

Redmond-based Physio-Control, which makes debrillators, said yesterday that it has acquired Jolife AB, a maker of a chest compression device for CPR. Financial terms of the deal were not disclose. Jolife AB is headquartered in Lund, Sweden....

Seattle-based Calistoga Pharmaceuticals, a developer of medicines to treat cancer and inflammatory diseases, has been acquired by Gilead Sciences in a $375M deal. According to the two firms, they are in a definitive agreement where Gilead w...

Beaverton, Oregon-based Inovise, a developer of medical instruments being used for cardiology, has raised $4.4M in an ongoing, $5.0M funding round, according to a recent regulatory filing from the firm. No details on the funding have been a...

Redmond-based Microsoft has linked its enterprise health intelligence software, Microsoft Amalga, with web-based practice management firm Athenahealth, the two said this morning. The two said they are in a strategic alliance which will conn...

Ricera Biosciences, LLC has sold its Efficacy Pharmacology operating unit, which is based in Bothell, Washington, to contract research firm Numira Biosciences. Numira said that it has acquired laboratory operations in Bothell, Washington, t...

Seattle-based Geospiza, the developer of software for the genetic analysis market, reported today that it has received a $1.2M phase II SBIR grant from the National Institutes of health. The firm said the grant will go towards developing a ...

Redmond-based Physio-Control, the developer of defibrillators used for treatment of sudden cardiac arrest, said today that it has inked a strategic partnership with BeneChill, a developer of therapeutic cooling systems. BeneChill's products...

Seattle-based PhysioSonics, a firm developing noninvasive neurological monitors, said this week that it has scored a Series B funding round. The round was led by Kirby Cramer, former Chairman of SonoSite, as well as undisclosed strategic in...

Seattle-based Calypso Medical Technologies, a developer of technology to track tumors, announced yesterday that it has named Edward Vertatschitsch as its President and CEO. Vertatschitsch has been at the firm since 2003, and was most recent...

Portland-based Kryptiq, a provider of healthcare software, reports today that South Carolina Oncology Associates (SCOA), has implemented its online bill payment software. Financial details of the win were not disclosed. Kryptiq said SCOA op...

Bothell-based OncoGenex Pharmaceuticals said this morning that it has named Michelle Burris as Executive Vice President, Operations, and Chief Financial Officers. Burris is currently a member of the firm's board, and previously served at SV...

Seattle-based Uptake Medical, a developer of treatments for emphysema, said today that it has named Dr. Steven Kesten as its Vice President and Chief Medical Officer. Uptake said that Dr. Kesten has previously served at Boehringer Ingelheim...

Seattle-based Mebik.org, a new, online resource focused on medical costs, said today that it has launched a new site which translates medical terms and codes into common language, and also helps people find local medical cost information. T...

Seattle-based Immune design Corp., a developer of immunotherapies and vaccines for infectious diseases and cancer, said today that it has entered into a license and development agreement with MedImmune. Financial details of the licensing de...

Seattle-based Omeros Corporation, the biopharmaceuticals firm focused on treating inflammation and disorders of the central nervous system, said yesterday that it has raised $25M, including $20M from Vulcan Capital, and $5M in a grant from ...

Vancouver, Washington-based Office Ally, a provider of electronic healthcare and other software for physicians and hospitals, said this morning that it has launched a new billing service for healthcare providers. According to the firm, its ...

Seattle-based Geospiza, a developer of gene sequencing tools, has inked a deal with European DNA sequencing services provider Eurofins MWG Operon. According to the firms, Eurofins is using Geospiza's GeneSifter Lab Edition to manage all of ...

Portland, Oregon-based SweetSpot Diabetes Care, a startup focus on using data from patient devices to improve diabetes care, said Tuesday that it has raised a round of initial funding. Amount of the funding was not disclosed. The round came...

Seattle-based ZymoGenetics, a developer of biotherapeutics for treating hepatitis C and metastatic melanoma, along with other disorders, is being acquired by Bristol-Myers Squibb. According to the firms, the deal is worth $9.75 per share in...

Seattle-based Stratos Genomics, a developer of DNA sequencing equipment for genome analysis and molecular diagnostics, announced Tuesday afternoon that it has raised $4M in a Series A funding. According to the firm, the round was led by Fis...

Seattle-based Geospiza, the developer of software for managing genetic analysis workflows, said Tuesday that it is in a collaboration with SAIC-Frederick Inc., a technical support contractor for the National Cancer Institute's research and ...

Redwood City-based EndoGastric Solutions, a developer of treatments for upper gastrointestinal diseases, including gastroesophageal reflux disease (GERD), announced today that it has raised $30M in a Series F financing round. The firm also ...

Bothell-based Blue Heron, a provider of gene synethesis services, has been acquired, according to Origene. According to Origene, which is a life sciences firm based in Rockville, Maryland, it acquired Blue Heron to expand its gene-centric t...

Seattle-based Trubion Pharmaceuticals said Thursday afternoon that it is in a definitive merger agreement with Emergent BioSolutions. According to the firm, the deal is worth approximately $96.8M up front, consisting of a $1.365 per share c...

Seattle-based HemaQuest Pharmaceuticals, a firm developing small molecule therapeutic treatments for sickle cell disease, beta thalassemia, and cancer, said today that it has raised and additional $4M in its Series B round, bringing the tot...

Seattle-based Immune Design Corp., a biotech firm focused on treatments for infectious disease and cancer, said today that it has raised $32M in a Series B funding round. The round was led by ProQuest Investments, and also included current ...

Seattle-based Integrated Diagnostics, the medical diagnostics firm founded by genome pioneer Dr. Leroy Hood, said today that it has raised $10M in a second tranche of its Series A funding. The firm said the move came due to "substantial pro...

Seattle-based Uptake Medical, a developer of medical devices for treating emphysema, announced today that it has raised $17.5M in a Series B funding round. The round was led by Maverick Capital, and also included prior investors GBS Venture...

Bothell-based SonoSite said Wednesday that it has completed its acquisition of Toronto-based ultrasound firm VisualSonics. The deal was worth $67.9M, net cash and debt. SonoSite said VisualSonics will become a wholly owned subsidiary of the...

Seattle-based Calistoga Pharmaceuticals, a developer of treatments for cancer and inflammatory disease, said today that it has raised $40M more in a Series C financing round. The round was led by Quogue Capital, and also included prior inve...

Seattle-based NanoString Technologies said this morning that it has named Brad Gray as its President and CEO, and Nalini Murdter, Ph.D. as its Chief Business Officer. Gray joins from Genzyme Genetics, and also has served at McKinsey & Compa...

Seattle-based Presage Biosciences, the spinout of the Fred Hutchinson Cancer Research Center, has upped its total funding to $3.8M, up from the $3.1M the firm announced in March. The additional funding was revealed through a regulatory fili...

Seattle-based Kineta, a firm developing biopharmaceutiacls to treat Type 1 diabetes, reported today that it has inked a new investment partnership with The Iacocca Family Foundation, to speed development of its compounds. Financial terms of...

Bothell, Washington-based Sonosite announced today that it has agreed to acquire Visualsonics, a developer of ultra high frequency micro-ultrasound technology. The deal is worth $71M in cash and debt. Sonosite said that Visualsonics' techno...

Portland-based Schrodinger, a firm focused on computational drug design for the pharmaceuticals and biotechnology research industry, said today that it has scored an investment from Cascade Investment, LLC, the investment firm of Bill Gates...

Seattle-based Mirina Corporation, a biotechnology firm focused on microRNA therapeutics, said today that it has closed on a Series A-1 financing. Size of the round was not disclosed. According to Mirina, the round was led by versant Venture...

Bothell-based Seattle Genetics, a biotechnology firm developing monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease, reported this morning that it will receive $9.5M in a payment from Genentech, as part of...

Spokane-based Signature Genomic Laboratories, a provider of diagnostic genetic testing services, has been acquired by PerkinElmer, PerkinElmer said today, in a deal worth $90M. According to PerkinElmer, the acquisition will strengthen the f...

Mercer Island-based Liberty Dialysis, which operates a network of dialysis centers, has scored new funding from private equity firm KRG Capital Partners, Bain Capital Ventures, and Ignition, according to KRG. According to the firm, the fund...

Seattle-based Dendreon announced today that it has added Varun Nanda as its Senior Vice President of Global Operations. Nanda joins the firm from Roche/Genentech, where he was Senior Vice President and Global Head of Oncology. Nanda has als...

Bothell-based MDRNA said Thursday that it has acquired Cequent Pharmaceuticals, a developer of RNAi-based therapeutics, in a deal worth $46M in stock. According to MDRNA, the acquisition will expand its oncology pipeline, and also provide t...

Bellevue-based Limeade, which runs employee wellness and health monitoring services, announced today that the firm has raised $3M in a financing round today. Source of the new funding was not disclosed. The firm also said that it has added ...

Cheetah Medical, a developer of noninvasive hemodynamic and cardiac output monitoring technology, said this week that it has raised $20M in a venture round. The firm, which has its U.S. headquarters in Portland, and international headquarte...

Redmond-based FiatLux Imaging, a developer of an Internet-based service for storing and sharing medical imaging data, announced that it has named Max Lyon as its CEO. Lyon has served as CEO and President of BioControl Systems, Bainbridge Sc...

Seattle-based Edge EHR Corp., a developer of electronic health records software, said Wednesday that it has signed a letter of intent to acquire Goal Software, Inc., based in Green Bay, Wisconsin. Financial terms ofthe acquisition were not ...

Portland, Oregon-based DeltaPoint is planning to accelerate its regulatory, product development and market education efforts with the recent $170,000 the firm garnered at last week's OEN Angel Oregon 2010 Launch State investment competition...

Seattle nonprofit research center The Institute for Systems Biology said Monday that it has received a $6M gift from an un-named California venture capitalist and philanthropist, to support the organization. According to the ISB, the fundin...

Bothell-based OncoGenex Pharmaceuticals, a firm developing and commercializing cancer therapies, said late Wednesday that its CFO, Steve Anderson, is leaving the firm. The company said that the company has launched a search for a new CFO. O...

Redmond-based Microsoft announced this morning that it has completed its acquisition of Sentillion, a developer of software for the healthcare industry. Microsoft said that Sentillion becomes part of its Microsoft Health Solutions Group, an...

Seattle-based biotech Dendreon said Thursday that it has named Hans Bishop as the firm's Chief Operating Officer. Bishop joins the company from Bayer, where he was president of that firm's specialty medicine business. Dendreon said that Bis...

Microsoft said Thursday that it is acquiring Sentillion, a developer of identity and access management technology for the healthcare industry. Financial terms of the buy were not disclosed. According to Microsoft, it will combine Sentillion...

Seattle-based Kineta, a developer of drugs targeted at autoimmune and viral diseases, said this morning that its development partner, Dr. K. George Chandy of the University of California, Irvine, has received a grant related to the firm's l...

Seattle-based ZymoGenetics, a developer of pharmaceutical products, reported in a filing yesterday that it has laid off 52 employees, or approximately 15% of its staff, as a part of an effort to "further align" the firm with opportunities. ...

EndoGastric Solutions, a developer of treatments for gastroesophageal reflux disease (GERD) and other GI disorders which has facilities in Redmond, said late last week that it has raised $21.5M in a Series E financing. The firm said the fun...

Seattle-based NanoString Technologies revealed this morning that it is in a research collaboratoin with the Broad Institute of MIT and Harvard. According to NanoString, the collaboration includes the investigation of molecular networks invo...

Seattle-based Trubion Pharmaceuticals is in the midst of an executive shakeup, saying Monday that Peter Thompson, the firm's Co-founder, President, CEO, and Chairman, has retired to "pursue other interests." The firm said that Steven Gillis...

Bothell-based Cardianc Science, a developer of automated external defibrillators (AEDs) and other cardiac monitoring devices, said today that it has linked with Cambridge Heart, a developer of noninvasive diagnostics tests for cardiac disea...

Bothell-based SonoSite, a developer of handheld ultrasound devices, said today that it has expanded the firm's SonoAccess iPhone application, to include musculoskeletal specialties. SonoSite initially introduced its iPhone app in June. The ...

A report released Friday by the We Work for Health finds that there are a total of 77,000 jobs now in Washington state. The Washington Life Sciences Economic Impact Study found that life sciences are directly responsible for 22,349 jobs in ...

Bothell-based SonoSite, a developer of portable ultrasound instruments, announced Monday that it has resolved a set of patent litigation suits with General Electric. The firm said that GE will pay SonoSite $21M, plus an ongoing royalty on U...

Seattle-based Dendreon announced today that it has added Ian Clark and Pedro Granadillo to the firm's board of directors. Clark is Head of Global Product Strategy and Chief Marketing Officer at Roche, Pharma Division, and is becoming CEO of...

Redmond-based Endogastric Solutions, a developer of medical devices for treating gastroesophageal reflex disease (GERD), has raised $2.0M in a funding round, according to a regulatory filing from the firm last week. According to the filing,...

Portland-based Clinicient, which develops outsourced physical therapy billing software, has raised another $250,000, according to a regulatory filing from the firm last week. The additional funding comes on top of $2.0M raise in March of th...

Seattle-based Uptake Medical, a developer of treatments for emphysema, has raised $4.5M in an ongoing, $13.3M round, according to a regulatory filing from the firm today. No details on the funding have been announced. The filing indicates t...

Bothell-based SonoSite, a developer of ultrasound systems, said today that it has rolled out a new software program targeted at managing ultrasound workflow. The firm said its new SonoSite Workflow Solution provides physicians with the abil...

Seattle-based Spiration, a maker of medical devices for treating emphysema, has raised $7M in a convertible debt round, according to a regulatory filing. According to reports, the funding came from Olympus Medical Systems. Spiration is back...

Seattle-based Integrative Diagnostics, a firm developing technology to detect cancer in the bloodstream, has raised $7.252M as part of an ongoing, $30.1M fundraising effort, according to a regulatory filing from the firm last week. No detai...

Seattle-based Calypso Medical Technologies said Thursday that it has raised $50M in a venture funding round. The firm, which develops medical technology for tracking tumors, said that the round was led by Skyline Ventures and Frazier Health...

Redmond-based Archus Orthopedics is shutting down its operations, as the firm failed to raise a funding round, according to a legal notice from the firm. Archus was venture backed by MPM Capital, InterWest Partners, Polaris Venture Partners...

Seattle-based Dendreon, which is developing treatments for advanced prostate cancer, said Monday that the firm is expanding in Atlanta with a new manufacturing facility. The firm said it has signed a lease agreement with Majestic Realty Co....

Seattle-based Confirma, a developer of software used for helping radiologists analyze MRI and other images, has been acquired by Milkwaukee-based Merge Healthcare. Merge said the all-stock transaction is worth approximately $22M, or 5.6 mi...

Seattle-based Oncothyreon, a publicly held biotech firm developing treatments for cancer, has scored $15M in a private placement in the publicly held firm. According to Oncothyreon, it is seeling 2.28 million shares of its common stock and ...

Bothell-based OncoGenex Pharmaceuticals, a developer of cancer treatments, announced this morning that it has raised $9.5M in a registered direct offering to institutional investors. The publicly held firm, which trades as OGXI on the Nasda...

Bothell-base OncoGenex Pharmaceuticals, which is focusing on treatments for cancer, disclosed Monday that the firm has inked a deal with institutional investors, where those investors will buy 475,000 shares of its common stock at $20 per s...

Portland-based Yecuris, a biotech startup spun out of Oregon Health and Science University, has raised $1.25M in a funding round, according to a regulatory filing from the firm today. According to the filing, the equity fundraising came fro...

Seattle-based Bio Architecture Lab, a startup out of the University of Washington, has raised $3.3M in an equity funding round, according to a regulatory filing from the firm today. Details on the funding have not been released by the compa...

Seattle venture capital firm OVP Venture Partners is the lead in the funding of a San Francisco firm developing biopharmaceuticals, according to the firm, Limerick BioPharma. Limerick, which develops compounds for reducing side effects in d...

Portland-based Kryptiq, a provider of software for healthcare collaboration, disclosed today that the firm has signed on the National Aeronautics and Space Administration (NASA) Space Medicine Division. Krptiq said that NASA's flight surgeo...

Redmond-based EndoGastric Solutions, a developer of medical devices for treating gastroesophageal reflex disease (GERD), has raised another $3.75M in funding for the firm, according to a regulatory filing from the firm today. The round come...

Bellevue-based PhysioSonics officially confirmed the firm's recent $2.0M financing in a second tranche of a Series A this morning, saying that the funding came from an unnamed strategic investor. The firm said the follow on investment bring...

Bothell, Washington-based SnoSite, a manufacturer of handheld ultrasound devices for the medical market, said Wednesday that the firm has rolled out a new, iPhone application which helps medical professionals access to information videos on...

Issaquah, Wash.-based Spacelabs Healthcare has sold its Clinical Trials Services division to Medifacts International Inc. of Rockville, Md., Medifacts announced this morning. Financial terms of the transaction were not disclosed. Spacelabs ...

Bellevue, Washington-based TranSenda, a developer of software for the clinical trial market, said Thursday that the firm has created a new product focused on improving access to centralized clinical trial data. The firm said its new product...

Bothell, Washington-based SonoSite, a publicly held firm developing ultrasound equipment, said Tuesday afternoon that it is in an agreement to acquire CardioDynamics International Corporation. According to SonoSite, the deal is worth approx...

Seattle-based NanoString Technologies, a developer of life sciences technology for characterizing biological samples, said today that the firm has raised $30M in a Series C equity financing. According to the firm, the round was led by Claru...

Redmond-based Microsoft announced Monday that the firm has signed an agreement with biotech giant Merck & Co., to acquire Rosetta Biosoftware, a developer of genetic data management software. Financial terms of the buy were not disclosed. A...

Bellevue-based Mediquest Therapeutics, which is developing products for the topical treatment of inflammatory and infectious diseases, has apparently raised $2.3M of an ongoing, $15M equity funding round, according to a regulatory filing fr...

Kirkland-based Pathway Medical Technologies disclosed Wednesday that the firm has closed its Series D investment round, adding new investor WRF Capital to the $42.5M funding. Pathway said that WRF invested $1.5M as part of its previously an...

Beaverton, Oregon-based Click Commerce, a provider of Web-based applications that assist with health care research, revealed Wednesday that a prominent public school will use its eResearch Portal software. The financial impact of the custom...

Redmond-based CoAptus Medical, which is developing non-implant, energy-based device to treat the heart condition patent foramen ovale (PFO), has raised $3.0M in an equity round of funding, according to a regulatory filing from the firm. CoA...

Seattle-based XORI, a biotech startup, has spun out of Accelerator Corp.. According to Accelerator, Xori is focused on technology for the rapid discovery and development of monoclonal antibodies (MAbs). Investors in the Series A funding inc...

Kirkland, Washington-based Proteotech has scored $519,401 in debt financing, according to a recent regulatory filing by the firm. Source of the debt financing was not disclosed. Proteotech develops treatments for Alzheimer's disease, Parkin...

Bellevue-based Aspen Medtech, a developer of medical device technology, has shut down, according to a report from VentureWire. Aspen Medtech was founded by Daniel Hawkins; the firm's executives were all previously at Seattle Medical Technol...

Seattle-based Targeted Genetics could be headed for bankruptcy. The publicly traded biotechnology firm suggested such could be a possibility in its first-quarter earnings report, which it made public Thursday. B.G. Susan Robinson, Targeted ...

Seattle-based Calistoga Pharmaceuticals, which is developing treatments for cancer and inflammatory diseases, said Tuesday that it has raised $30M in a Series B funding round. Calistoga said that the funding came from Alta Partners, Amgen V...

Seattle-based ZymoGenetics reported Monday that it has licensed the rights to eight of the firm's early stage product candidates to Seattle Life Sciences. Financial impact of the deal was not disclosed. According to Zymogenetics, it is enti...

Seattle-based ZymoGenetics, which is developing protein-based drugs, said Wednesday that it has cut 161 employees, or 32 percent of its staff. The firm said the move will save it approximately $30M in annual operating expenses. The firm sai...

Portland-based Kryptiq, publisher of a doctor-to-patient collaborative platform, announced Tuesday that it has sold its Choreo health plan network management software to Portico Systems. Financial terms of the transaction were not disclosed...

Cell Therapeutics announced late Monday that an institutional investor has purchased $15 million of Series 1 Preferred Stock and associated warrants and might buy up to $5 million more within the next 60 days. CTI, which develops therapies ...

Portland, Oregon-based CollegeNET, a developer of web-based software for educational institutions, said today that the firm has created a new division focused on medical records automation. CollegeNET said its new Medical Records division w...

Seattle-based Cell Therapeutics, which is developing cancer treatment drugs, said Friday morning that the firm has received a notice from the NASDAQ, saying that it is in full compliance with requirements for continued listing on the NASDAQ...

Seattle-based Rosetta Biosoftware, a maker of products for genetic data management and analysis, said Tuesday that the firm has signed on Stanford University as a licensee. According to the firm, Stanford will use the firm's products as par...

Kirkland, Washington-based Pathway Medical Technologies announced this morning that the firm has raised $40M in a Series D funding round. According to the firm, the funding came from Forbion Capital Partners, HLM Venture Partners, Latterell...

Bothell, Wash.-based MDRNA, a biotechnology firm developing products based on RNA interference, said Monday that it is in a licensing agreement with Novartis. According to MDRNA, Novartis will license its liposomal technology platform for s...

Seattle-based Cell Therapeutics, which is developing chemotherapy drugs, said Friday that it is closing its European operations and laying off a total of 62 employees. According to Cell Therapeutics, the move is expected to save it $14M in ...

A Florida-based venture capital firm announced recently that it has invested $3 million into MolecularMD Corp. According to Ballast Point Ventures, MolecularMD will use the funds to finance expansion of its assay portfolio and corporate inf...

Bothell, Washington-based Ekos, which develops medical devices for treating blood clots, has raised $12.5M in a round, according to reports. According to Xconomy, Ekos raised the Series D funding from Crown Venture Fund, in a deal which als...

Seattle-based Omeros reported Wednesday that the firm has gained $3.1M in a second tranche of equity and grant funding, for the firm's candidates for the treatment of schizophrenia. The firm said the funding came from The Stanley Medical R...

Bothell, Washington-based Cardiac Science, a developer of defibrillators, electrocardigraph devices, and other medical equipment, said late Wednesday that it is cutting approximately 12% of its current staff, and reducing other expenses. Th...

Seattle-based Omeros has scored a research grant from the Michael J. Fox Foundation, the firm said Tuesday, worth $465,000. The pharmaceuticals developer said that the grant is a part of an effort to treat Parkinson's disease with its compo...

Seattle-based Northstar Neuroscience said late Monday morning that the firm plans to shut down, and will liquidate the company's assets. The firm, which was looking to develop medical devices to treat major depressive disorder, said its boa...

Seattle-based Oncothyreon, a developer of cancer treatments, said Thursday that it has sold off a product line to Merck, in a deal worth $13M. Oncothyreon said it sold manufacturing rights to Stimuvax to Merck, via Merck's Canadian affiliat...

Portland-based Kryptiq Corp. announced Thursday that it has scored a patent from the U.S. Patent and Trademark Office. The firm, which operates and information network for patient data, said the patent covers its technique for encrypting an...

Seattle-based Washington Life Sciences Discovery Fund (LSDF) said this week that it has awarded nearly $4.7M to the Washington Vaccine Alliance (WAVA), for a program to help research new vaccines for E. coli, herpes and syphilis. The progra...

Bothell, Wash.-based biopharmaceutical firm Cardiac Science Corp. reported Tuesday that it has appointed a new board member and accepted the resignation of two others. The company said the changes, which will leave the board with seven dir...

Merck & Co. Inc. announced Wednesday that it plans to close its basic research facility in Seattle's South Lake Union district by the end of 2009. The pharmaceutical manufacturer said the impending closure is part a global restructuring eff...

Seattle-based Omeros, which is developing biopharmaceuticals for treating inflammation and central nervous system disorders, said Wednesday that it has established a $20M, debt facility with BlueCrest Capital Finance. Omeros said that the d...